Abstract:Objective:Invasive infections due to Candida spp. have unique epidemiology, strain distribution, antimicrobial susceptibility, and clinical features. This study aimed to compare and evaluate these characteristic variables between invasive Candida infection and colonization of critically ill patients in local China to potentially improve differential diagnosis and therapy.Methods:A total of 193 critically ill patients were recruited and followed up for the study, and 133 Candida isolates were obtained from invasive Candida-infected or -colonized subjects. The strains were identified to species level through matrix-assisted laser desorption/ionization-time-of-flight mass spectrometry, assisted by DNA sequencing. Candida susceptibility to common antifungals, including azoles, was determined by microbroth ATB Fungus 3 methodology. Azole resistance-related gene sequencing and homologous 3D-structure modeling were employed. Patient demographics and clinical risk factors were documented and comparatively analyzed from the hospital information-management system.Results:Non-C. albicans Candida (56%) principally caused invasive Candida infections, while C. albicans (55.17%) contributed more to Candida colonization in critically ill patients. Additional risk factors exerted significant impact on both Candida cohorts, primarily including invasive interventions, cancers, and concurrent infections in common. Most colonized Candida spp. harbored relatively higher sensitivity to azoles. ERG11 gene mutations of T348A and A1309G, A395T and C461T, and a novel G1193T to our knowledge were identified in azole-resistant C. albicans, C. tropicalis, and C. parapsilosis respectively, and their corresponding homologous 3D-structure modeling was putatively achieved.Conclusion:Distinct epidemiological and clinical characteristics existed between invasive Candida infection and colonization in critically ill patients. Multiple risk factors significantly involved both the Candida cohorts. Colonized Candida exhibited generally higher azole sensitivity than invasively infectious counterparts. ERG11 point mutations had mechanistically potential ties with local Candida resistance to azoles.

Evaluation of colonization index and (1,3)- ß- D glucan as diagnostic tools of invasive candidiasis in a pediatric Intensive Care Unit

Invasive Candidiasis in Intensive Care Units in China: a Multicentre Prospective Observational Study

Prognostic value of serial (1,3)-β-d-glucan measurements in ICU patients with invasive candidiasis

A scoring system based on novel biomarkers and clinical risk factors to predict invasive candidiasis in immunocompetent critically ill patients

Invasive Candidiasis in Intensive Care Units in China: in Vitro Antifungal Susceptibility in the China-SCAN Study

Monocyte human leukocyte antigen-DR but not β-d-glucan may help early diagnosing invasive Candida infection in critically ill patients

Invasive Candidiasis in Intensive Care Units in China: Risk Factors and Prognoses of Candida Albicans and Non-Albicans Candida Infections

Clinical evaluation of two different (1,3)-ß-d-glucan assays for diagnosis of invasive fungal diseases: A retrospective cohort study

Detection of Candida DNA in peritoneal fluids by PCR assay optimizing the diagnosis and treatment for intra-abdominal candidiasis in high-risk ICU patients: A prospective cohort study

Insights into Candida Colonization in Intensive Care Unit Patients: A Prospective Multicenter Study

Deciphering the epidemiology of invasive candidiasis in the intensive care unit: is it possible?

Lower (1,3)-beta-d-glucan (BDG) sensitivity and in-vitro levels in Candida auris and Candida parapsilosis strains

Diagnostic performance of the (1-3)-β-d-glucan assay in patients with different risks for invasive fungal diseases

High frequency of Candida krusei colonization in critically ill pediatrics: A cross-sectional study in Children’s Medical Center, Tehran, Iran

Comparative Analysis of Epidemiological and Clinical Characteristics Between Invasive Candida Infection Versus Colonization in Critically Ill Patients in a Tertiary Hospital in Anhui, China

[Is the use of antifungal management advisable in critical patients with positive isolation of Candida spp. from intraabdominal clinical samples?]

The Diagnostic Accuracy of Procalcitonin and Its Combination with Other Biomarkers for Candidemia in Critically Ill Patients

Clinical Features and Prognostic Risk Factors of Candidemia in Non-Intensive Care Unit Wards

A Ten-year Retrospective Study of Invasive Candidiasis in a Tertiary Hospital in Beijing.

Antifungal susceptibility, molecular epidemiology, and clinical risk factors of Candida glabrata in intensive care unit in a Chinese Tertiary Hospital

Epidemiology, Clinical Characteristics, and Risk Factors for Mortality of Early- and Late-Onset Invasive Candidiasis in Intensive Care Units in China.